REQUEST A DEMO
Total
USD $0.00
Search more companies

U-Neuron Biomedical Inc. (Taiwan, China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: U-Neuron Biomedical Inc. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

U-Neuron Biomedical Inc. is committed to the research and development of stem cell storage, isolation and treatment application technologies. It is a company with patents for amniotic fluid stem cell culture technology. The company's main products include amniotic fluid stem cells, adipose stem cells, and stored amniotic fluid stem cells. The company was established in 2015 and is headquartered in New Taipei City, Taiwan.

Headquarters
18F-5,No.99, Sec.1,Xintai 5Th Rd, Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the U-Neuron Biomedical Inc. report to view the information.

Website: http://www.u-neuron.com

Basic Information
Outstanding Shares:
Purchase the U-Neuron Biomedical Inc. report to view the information.
Financial Auditors:
Purchase the U-Neuron Biomedical Inc. report to view the information.
Incorporation Date:
December 08, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Subsidiaries
永艾芙生醫有限公司
100%
Company Performance
Financial values in the chart are available after U-Neuron Biomedical Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
92.71%
Total operating revenue
91.22%
Operating profit (EBIT)
20.56%
EBITDA
27.81%
Net Profit (Loss) for the Period
27.41%
Total assets
59.72%
Total equity
61.62%
Operating Profit Margin (ROS)
100.68%
Net Profit Margin
96.92%
Return on Equity (ROE)
3.87%
Debt to Equity Ratio
0.86%
Quick Ratio
11.21%
Cash Ratio
4.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?